第一作者机构:[1]Capital Med Univ, Xuanwu Hosp, Dept Neurol, 45 Changchun Rd, Beijing 100053, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Li Hai-Feng,Hu Shi-Min,Han Wei,et al.Regarding the "Efgartigimod versus standard of care in new-onset AChR subtype generalized myasthenia gravis: A prospective cohort study"[J].CLINICAL IMMUNOLOGY.2025,281:doi:10.1016/j.clim.2025.110603.
APA:
Li, Hai-Feng,Hu, Shi-Min,Han, Wei&Guo, Yan-Su.(2025).Regarding the "Efgartigimod versus standard of care in new-onset AChR subtype generalized myasthenia gravis: A prospective cohort study".CLINICAL IMMUNOLOGY,281,
MLA:
Li, Hai-Feng,et al."Regarding the "Efgartigimod versus standard of care in new-onset AChR subtype generalized myasthenia gravis: A prospective cohort study"".CLINICAL IMMUNOLOGY 281.(2025)